EJS ACT-PD is a clinical trial testing new treatments for Parkinson's disease, to slow or stop Parkinson's disease progression.
EJS ACT-PD will improve efficiency by testing more treatments, more quickly and seamlessly continuing the evaluation of only those treatments that look the most promising.
Join the EJS ACT-PD Trial!
(Alt Text: A laptop and various office supplies arranged neatly on a desk.)
If you are interested in joining the EJS ACT-PD Trial,
register your interest by visiting our Registration of Interest Page.
The Edmond J. Safra Accelerating Clinical Trials for Parkinson’s Disease (EJS ACT-PD) platform aims to transform the way Parkinson’s clinical trials are conducted in the UK. As a multi-arm, multi-stage (MAMS) trial platform, EJS ACT-PD will evaluate several potentially disease-modifying treatments in parallel against a shared placebo (dummy drug) group, accelerating the search for effective treatments by testing more drugs faster and more efficiently than ever before.
Watch Cure Parkinson's explainer video below
I would like to find out more
Click on the images below to find out more about each of these topics
About Us
Find out more about the EJS ACT-PD Trial, the people and organisations running the trial and our funders.
For Participants
If you are a potential participant or a family member looking for more information about EJS ACT-PD trial, visit the For Participants Page.
Trial Updates
Read the latest news and updates from the trial, including publications.